Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Innohep approved by FDA for DVT

July 20, 2000

FDA clears ConjuChem to initiate phase I/II trial of thrombin inhibitor

July 18, 2000

Berlex presents newly synthesized series of anticoagulants

July 17, 2000

Biopure reaches enrollment milestone in pivotal phase III trial of Hemopure

July 17, 2000

Novo Nordisk presents new heterocyclic inhibitors of factor VIIa-TF activity

July 12, 2000

Anticoagulant 2-pyridones under study at Sanofi-Synthelabo

July 10, 2000

Merck KGaA describes new series of compounds for thrombotic disorders

July 10, 2000

DuPont and Emisphere reach agreement on oral heparins

July 10, 2000

Antagonists of platelet adhesion receptor in development at Merck as antithrombotics

July 7, 2000

Anticoagulants from Berlex act by inhibiting factor Xa

July 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...